http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0170775-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-08
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-34
filingDate 1982-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1994-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3897c07bd8a093bd2e10802e9d132d80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50592ab5d2f82a84ff8cc6f60f4761bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4152d980d27c667c5466fcf178495435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_183f813c77de56a829af2407e23d9597
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3f1edad3daaea636e0b8d321e1f77fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41ecbdfbcf11ca78c5ca25ee1b5f2386
publicationDate 1994-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0170775-B2
titleOfInvention Derivatives of bicyclic amino acids, processes for their preparation, agents containing them and their use as well as bicyclic amino acids as intermediates and process for their preparation
abstract 1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE A compound of the formula I see diagramm : EP0170775,P20,F2 in which the hydrogen atoms on the bridgehead carbon atoms 3a and (6+n)a have the cis or trans configuration relative to one another, wherein, in the case of the cis configuration, the carboxyl group or carbon atom 2 is oriented exo to the bicyclic ring system and wherein n denotes 0, 1 or 2, R1 denotes hydrogen, (C1 -C6 )-alkyl which can optionally be substituted by amino, (C1 -C4 )-acylamino or benzoylamino, (C2 -C6 )-alkenyl, (C5 -C9 )-cycloalkyl, (C5 -C9 )-cycloalkenyl, (C5 -C7 )-cycloalkyl-(C1 -C4 )-alkyl, aryl or partially hydrogenated aryl, which can, in each case, be substituted by (C1 -C4 )-alkyl, (C1 -C2 )-alkoxy or halogen, aryl-(C1 -C4 )-alkyl, which can be substituted as defined previously in the aryl radical, a monocyclic or bicyclic heterocyclic radical having 5 to 7 or 8 to 10 ring atoms respectively, of which 1 to 2 ring atoms are sulfur or oxygen atoms and/or of which 1 to 4 ring atoms are nitrogen atoms, or a side chain of a naturally occuring amino acid, R2 denotes hydrogen, (C1 -C6 )-alkyl, (C2 -C6 )-alkenyl or aryl-(C1 -C4 )-alkyl, R' denotes hydrogen, benzyl or tert. butyl, Y denotes hydrogen or hydroxyl, Z denotes hydrogen or Y and Z together denote oxygen, X denotes (C1 -C6 )-alkyl, (C2 -C6 )-alkenyl, (C5 -C9 )-cycloalkyl, aryl which can be mono-, di- or tri-substituted by (C1 -C4 )-alkyl, (C1 -C4 )-alkoxy, hydroxyl, halogen, nitro, amino, (C1 -C4 )-alkylamino, di-(C1 -C4 )-alkylamino or methylenedioxy, or indol-3-yl, and aryl denotes phenyl or naphthyl, and the physiologically acceptable salts thereof, excluding compounds of the formula I in which the hydrogen atoms on the bridgehead carbon atoms 3a and (6+n)a have the trans configuration relative to one another and wherein R1 denotes methyl, R2 denotes hydrogen, (C1 -C4 )-alkyl or benzyl, R' denotes hydrogen and X denotes phenyl and n, Y and Z are as defined above, as well as the salts thereof. 1. Claims for the Contracting State : AT A process for the preparation of a compound of the formula I see diagramm : EP0170775,P23,F4 in which the hydrogen atoms on the bridgehead carbon atoms 3a and (6+n)a have the cis or trans configuration relative to one another, wherein, in the case of the cis configuration, the carboxyl group on carbon atom 2 is oriented exo to the bicyclic ring system and wherein n denotes 0, 1 or 2, R1 denotes hydrogen, (C1 -C6 )-alkyl, which can optionally be substituted by amino, (C1 -C4 )-acylamino or benzoylamino, (C2 -C6 )-alkenyl, (C5 -C9 )-cycloalkyl, (C5 -C9 )-cycloalkenyl, (C5 -C7 )-cycloalkyl-(C1 -C4 )-alkyl, aryl or partially hydrogenated aryl, which can, in each case, be substituted by (C1 -C4 )-alkyl, (C1 -C2 )-alkoxy or halogen, aryl-(C1 -C4 )-alkyl, which can be substituted as defined previously in the aryl radical, a monocyclic or bicyclic heterocyclic radical having 5 to 7 or 8 to 10 ring atoms respectively, of which 1 to 2 ring atoms are sulfur or oxygen atoms and/or of which 1 to 4 ring atoms are nitrogen atoms, or a side chain of a naturally occurring amino acid, R2 denotes hydrogen, (C1 -C6 )-alkyl, (C2 -C6 )-alkenyl or aryl-(C1 -C4 )-alkyl, R' denotes hydrogen, benzyl or tert. butyl, Y denotes hydrogen or hydroxyl, Z denotes hydrogen or Y and Z together denote oxygen, X denotes (C1 -C6 )-alkyl, (C2 -C6 )-alkenyl, (C5 -C9 )-cycloalkyl, aryl which can be mono-, di- or tri-substituted by (C1 -C4 )-alkyl, (C1 -C4 )-alkoxy, hydroxyl, halogen, nitro, amino, (C1 -C4 )-alkylamino, di-(C1 -C4 )-alkylamino or methylenedioxy, or indol-3-yl, and aryl denotes phenyl or naphthyl, and the physiologically acceptable salts thereof, excluding compounds of the formula I in which the hydrogen atoms on the bridgehead carbon atoms 3a and (6+n)a have the trans configuration relative to one another and wherein R1 denotes methyl, R1 denotes hydrogen, (C1 -C4 )-alkyl or benzyl, R' denotes hydrogen and X denotes phenyl and n, Y and Z are as defined above, as well as the salts thereof, which a) comprises reacting a compound of the formula II see diagramm : EP0170775,P23,F2 wherein R1 , R2 , X, Y and Z have the meanings as in formula I, with a compound of the formula III see diagramm : EP0170775,P23,F3 in which the hydrogen atoms on the carbon atoms 3a and (6+n)a have the cis or trans configuration relative to one another, wherein, in the case of the cis configuration, the group -CO2 W is oriented exo to the bicyclic ring system and wherein n denotes 0, 1 or 2 and W denotes a radical which can be cleaved off by hydrogenolysis or by acid, and subsequently cleaving off, if appropriate, the radical W and, if appropriate, the radical R2 to form the free carboxyl group(s), or b) for the preparation of compounds of the formula I in which Y and Z together denote oxygen, comprises b1 ) reacting a compound of the formula IV see diagramm : EP0170775,P23,F5 in which the hydrogen atoms on the carbon atoms 3a and (6+n)a have the cis or trans configuration relative to one another, wherein, in the case of the cis configuration, the group -CO2 W is oriented exo to the bicyclic ring system, and wherein n and R1 have the meanings as in formula I and W has the meaning as in formula III, with a compound of the formula V, R2 O2 C-CH=CH-CO-X wherein R2 and X have the meanings as in formula I, and subsequently cleaving off, if appropriate, the radical W and, if appropriate, also the radical R2 to form the free carboxyl group(s), or b2 ) reacting a compound of the formula IV mentioned under b1 ) with a compound of the general formula VI wherein R2 has the meaning as in formula I, and with a compound of the general formula VII OHC-CO2 R2 X-CO-CH3 wherein X has the meaning as in formula I, and subsequently cleaving off, if appropriate, the radical W and, if appropriate, the radical R2 to form the free carboxyl group(s), or c) for the preparation of compounds of the formula I in which Y and Z each denote hydrogen, comprises c1 ) reacting a compound of the formula IV mentioned unter b1 ) with a compound of the formula VIII see diagramm : EP0170775,P24,F1 wherein R2 and X have the meanings as in formula I, reducing the Schiff's bases obtained and subsequently cleaving off, if appropriate, the radical W and, if appropriate, the radical R2 to form the free carboxyl group(s), or c2 ) catalytically reducing with hydrogen a compound of the formula I in which Y and Z together denote oxygen, or d) for the preparation of compounds of the formula I in which Y denotes hydroxyl and Z denotes hydrogen, comprises reducing a compound of the formula I in which Y and Z together denote oxygen, catalytically with hydrogen or with a reducing agent, such as sodium borohydride, and converting the compounds obtained as in (a)-(d), if appropriate, into the physiologically tolerated salts thereof.
priorityDate 1981-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67832845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228569577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54457772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227280737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12265805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53728730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466390496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54073550
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234775250
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID586355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234775248
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227453864
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18639676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234771662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13044262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234771546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231584151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26338868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18639673
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234771508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87189524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234771482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231381388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234771271
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21612069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393315

Total number of triples: 67.